Research Article
Data-Driven Discovery of Molecular Targets for Antibody-Drug Conjugates in Cancer Treatment
Table 3
Correlation of target
-scores with corresponding FPKM values for different tumor types.
| Tumor type | Correlation coefficient | |
| Breast cancer | 0.383 | 0.071 | Cervical cancer | 0.490 | 0.018 | Colorectal cancer | 0.318 | 0.139 | Endometrial cancer | 0.553 | 0.006 | Glioma | 0.597 | 0.003 | Head and neck cancer | 0.516 | 0.012 | Liver cancer | 0.581 | 0.004 | Lung cancer | 0.517 | 0.012 | Melanoma | 0.685 | <0.001 | Ovarian cancer | 0.312 | 0.147 | Pancreatic cancer | 0.468 | 0.024 | Prostate cancer | 0.530 | 0.009 | Renal cancer | 0.738 | <0.001 | Stomach cancer | 0.403 | 0.057 | Testis cancer | 0.358 | 0.093 | Thyroid cancer | 0.463 | 0.026 | Urothelial cancer | 0.608 | 0.002 |
|
|